Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 7
1948 8
1949 7
1950 8
1951 17
1952 13
1953 10
1954 19
1955 27
1956 22
1957 18
1958 18
1959 13
1960 4
1961 4
1962 4
1963 8
1964 9
1965 7
1966 9
1967 9
1968 24
1969 20
1970 20
1971 9
1972 11
1973 19
1974 20
1975 22
1976 20
1977 32
1978 24
1979 15
1980 11
1981 21
1982 19
1983 27
1984 23
1985 30
1986 32
1987 38
1988 38
1989 42
1990 32
1991 41
1992 52
1993 50
1994 51
1995 49
1996 64
1997 53
1998 75
1999 58
2000 93
2001 97
2002 134
2003 98
2004 105
2005 106
2006 124
2007 161
2008 172
2009 166
2010 211
2011 233
2012 270
2013 255
2014 236
2015 245
2016 288
2017 281
2018 289
2019 282
2020 326
2021 396
2022 404
2023 332
2024 288
2025 293

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,483 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Obermayer A, Tripolt NJ, Pferschy PN, Kojzar H, Aziz F, Müller A, Schauer M, Oulhaj A, Aberer F, Sourij C, Habisch H, Madl T, Pieber T, Obermayer-Pietsch B, Stadlbauer V, Sourij H. Obermayer A, et al. Among authors: muller a. Diabetes Care. 2023 Feb 1;46(2):463-468. doi: 10.2337/dc22-1622. Diabetes Care. 2023. PMID: 36508320 Free PMC article. Clinical Trial.
Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis.
Manjaly ZM, Harrison NA, Critchley HD, Do CT, Stefanics G, Wenderoth N, Lutterotti A, Müller A, Stephan KE. Manjaly ZM, et al. Among authors: muller a. J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):642-651. doi: 10.1136/jnnp-2018-320050. Epub 2019 Jan 25. J Neurol Neurosurg Psychiatry. 2019. PMID: 30683707 Free PMC article. Review.
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.
Kruse B, Buzzai AC, Shridhar N, Braun AD, Gellert S, Knauth K, Pozniak J, Peters J, Dittmann P, Mengoni M, van der Sluis TC, Höhn S, Antoranz A, Krone A, Fu Y, Yu D, Essand M, Geffers R, Mougiakakos D, Kahlfuß S, Kashkar H, Gaffal E, Bosisio FM, Bechter O, Rambow F, Marine JC, Kastenmüller W, Müller AJ, Tüting T. Kruse B, et al. Among authors: muller aj. Nature. 2023 Jun;618(7967):1033-1040. doi: 10.1038/s41586-023-06199-x. Epub 2023 Jun 14. Nature. 2023. PMID: 37316667 Free PMC article.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, Kato K, Sureda A, Greil R, Thieblemont C, Morschhauser F, Janz M, Flinn I, Rabitsch W, Kwong YL, Kersten MJ, Minnema MC, Holte H, Chan EHL, Martinez-Lopez J, Müller AMS, Maziarz RT, McGuirk JP, Bachy E, Le Gouill S, Dreyling M, Harigae H, Bond D, Andreadis C, McSweeney P, Kharfan-Dabaja M, Newsome S, Degtyarev E, Awasthi R, Del Corral C, Andreola G, Masood A, Schuster SJ, Jäger U, Borchmann P, Westin JR. Bishop MR, et al. Among authors: muller ams. N Engl J Med. 2022 Feb 17;386(7):629-639. doi: 10.1056/NEJMoa2116596. Epub 2021 Dec 14. N Engl J Med. 2022. PMID: 34904798 Clinical Trial.
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors.
Montalban-Arques A, Katkeviciute E, Busenhart P, Bircher A, Wirbel J, Zeller G, Morsy Y, Borsig L, Glaus Garzon JF, Müller A, Arnold IC, Artola-Boran M, Krauthammer M, Sintsova A, Zamboni N, Leventhal GE, Berchtold L, de Wouters T, Rogler G, Baebler K, Schwarzfischer M, Hering L, Olivares-Rivas I, Atrott K, Gottier C, Lang S, Boyman O, Fritsch R, Manz MG, Spalinger MR, Scharl M. Montalban-Arques A, et al. Among authors: muller a. Cell Host Microbe. 2021 Oct 13;29(10):1573-1588.e7. doi: 10.1016/j.chom.2021.08.001. Epub 2021 Aug 27. Cell Host Microbe. 2021. PMID: 34453895 Free article.
The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis.
Woo MS, Brand J, Bal LC, Moritz M, Walkenhorst M, Vieira V, Ipenberg I, Rothammer N, Wang M, Dogan B, Loreth D, Mayer C, Nagel D, Wagner I, Pfeffer LK, Landgraf P, van Ham M, Mattern KM, Winschel I, Frantz N, Sonner JK, Grosshans HK, Miguela A, Bauer S, Meurs N, Müller A, Binkle-Ladisch L, Salinas G, Jänsch L, Dieterich DC, Riedner M, Krüger E, Heppner FL, Glatzel M, Puelles VG, Engler JB, Nyengaard JR, Misgeld T, Kerschensteiner M, Merkler D, Meyer-Schwesinger C, Friese MA. Woo MS, et al. Among authors: muller a. Cell. 2025 Aug 21;188(17):4567-4585.e32. doi: 10.1016/j.cell.2025.05.029. Epub 2025 Jun 17. Cell. 2025. PMID: 40532699 Free article.
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death.
Alvarez-Valadez K, Sauvat A, Diharce J, Leduc M, Stoll G, Guittat L, Lambertucci F, Paillet J, Motiño O, Ferret L, Muller A, Forveille S, Maiuri MC, Kepp O, de Brevern AG, Wodrich H, Pol JG, Kroemer G, Djavaheri-Mergny M. Alvarez-Valadez K, et al. Among authors: muller a. Autophagy. 2025 May;21(5):934-956. doi: 10.1080/15548627.2024.2440842. Epub 2024 Dec 27. Autophagy. 2025. PMID: 39663580
EBV induces CNS homing of B cells attracting inflammatory T cells.
Läderach F, Piteros I, Fennell É, Bremer E, Last M, Schmid S, Rieble L, Campbell C, Ludwig-Portugall I, Bornemann L, Gruhl A, Eulitz K, Gueguen P, Mietz J, Müller A, Pezzino G, Schmitz J, Ferlazzo G, Mautner J, Münz C. Läderach F, et al. Among authors: muller a. Nature. 2025 Oct;646(8083):171-179. doi: 10.1038/s41586-025-09378-0. Epub 2025 Aug 6. Nature. 2025. PMID: 40770101
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Huober J, Weder P, Ribi K, Thürlimann B, Thery JC, Li Q, Vanlemmens L, Guiu S, Brain E, Grenier J, Dalenc F, Levy C, Savoye AM, Müller A, Membrez-Antonioli V, Gérard MA, Lemonnier J, Hawle H, Dietrich D, Boven E, Bonnefoi H; Swiss Group for Clinical Cancer Research, Unicancer Breast Group, and Dutch Breast Cancer Research Group. Huober J, et al. Among authors: muller a. JAMA Oncol. 2023 Oct 1;9(10):1381-1389. doi: 10.1001/jamaoncol.2023.2909. JAMA Oncol. 2023. PMID: 37561451 Free PMC article. Clinical Trial.
6,483 results